According to the Low Dose Naltrexone home page [LDN],
LDN has been seen to benefit IBS, which is considered to be an autoimmune disease.
Dr. Jill Cottel also reports successfully treating irritable bowel syndrome using LDN
[Elsegood2016, pg xviii].
[Toljan2018 🕮 ] [Kariv2006 🕮 ] reports a 4-week trial of 0.5mg LDN with 42 IBS patients. Global assessment showed an improvement in 76% the participants, with the mean number of pain-free days
increasing significantly from 0.5 to 1.25 days. Dr. Weyrich notes that this was a relatively low dose,
and better response might be expected with dose titration towards the usual dose of LDN of 4.5mg/day.
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of IBS with LDN.
Please see What is Low Dose Naltrexone?
for more information.
Neuro Research [Hinz2015] reports that irritable bowel syndrome
can be benefited by balancing neurotransmitter levels in the body.
Dr. Weyrich has been trained in neurotransmitter balancing protocols, but has not treated
irritable bowel syndrome using this technique.
Please see What is Neurotransmitter Balancing?
for more information.